Purchase Order 75N92024P00229
Award Date 9/29/24
Potential Completion Date 9/28/25
Potential Value $26K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), awarded a $11,335.87 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract is for the provision of various Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with accompanying consumables, support services, and bioinformatics products. This delivery order award is under a broader...
- This is a firm fixed-price purchase order contract awarded to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies, by the National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH). The $25,959 contract is for the provision of NEXTSEQ2000 sequencing services and has an ultimate completion date of September 28, 2026. The contract was awarded on September 29, 2025 and does not utilize...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $149,627.88, was awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is a delivery order and is a firm fixed-price arrangement, with no set-aside designation. Illumina has previously provided a range of sequencing systems, reagents,...
- This federal contract award to Illumina, Inc. is a delivery order valued at $35,935.00 for the provision of genomic sequencing systems, reagents, and related services. The award was made by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian agency. The contract is a firm fixed price arrangement with no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments, has received numerous prior...
- The U.S. National Human Genome Research Institute (NHGRI), a civilian agency, awarded a firm-fixed-price purchase order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and consumables, for the purchase of Illumina MiSeq i100 Plus Systems. The $290,026.10 contract has an ultimate completion date of November 1, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a key technology provider for federal scientific...
- This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for the delivery of NextSeq sequencing kits. The $6,849.50 firm fixed price delivery order contract has an ultimate completion date of August 31, 2015 and was awarded on September 10, 2013. No set-aside designation was used. Illumina is a manufacturer and provider of sequencing and genomic analysis solutions, and has...
- The U.S. National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH), awarded a $102,215.22 firm fixed-price delivery order contract to Illumina, Inc. This order is part of a larger Indefinite Delivery Contract between Illumina and the Department of the Navy Bureau of Medicine and Surgery, valued up to $3.3 million, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. The...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $5,906.00. The contract does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. Under this order, Illumina will provide various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, sample prep kits,...
- This federal contract award to Illumina, Inc. was issued by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH). The $159,746.65 firm fixed price delivery order contract is for the provision of Illumina's proprietary sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis. This appears to be a follow-on to previous prime contracts Illumina has held with various federal agencies for similar...
- Illumina, Inc. has been awarded a delivery order valued at $217,193.76 by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health. This firm fixed-price delivery order, issued on July 17, 2025, with an ultimate completion date of May 21, 2026, will be performed at Illumina's facility in San Diego, California. The contract carries no set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technologies. As...